It's #PCFRetreat19 week! This is our 26th Annual PCF Scientific Retreat and we're so excited to be bringing together the brightest minds in science to discuss the most significant & promising new #prostatecancer research. Stay tuned to our pages for updates throughout!

#pcfselfie19 #table6 #sciencedomination Deli Liu, PhD Anu Jayaram Francesca Lorenzin Simpa Salami

World PCF family, woowww ⁦PCF Science⁩ ⁦Prostate Cancer Foundation⁩ #PCFRetreat19

#PCFRetreat19 PCFYIA class of 2019 PCF Science Prostate Cancer Foundation

Great thanks to PCF Science Prostate Cancer Foundation Howard Soule , and my great mentors Chris Barbieri Andrea Sboner, PhD @[email protected]

Very proud to be involved in this project, and great thanks to my mentors Chris Barbieri Andrea Sboner, PhD @[email protected] , and many others!

Scientists: Support for the innovation engine of American science: immigrants - Sign the Petition! chng.it/Kcg4JFwy via Change.org

New release of our MAESTRO pipeline for integrative analysis of #scRNAseq and #scATACseq data with many more new features: github.com/liulab-dfci/MA…

A friendly reminder of what the Barbieri Lab believes!

The Barbieri Lab is hiring Postdocs! Please share indeedjobs.com/weill-cornell-…

Amazing work by Ivana Grbesa defining the epigenetic consequences of SPOP mutations in normal prostate epithelial cells and the implications for therapeutic response!! Chris Barbieri Prostate Cancer Foundation biorxiv.org/content/10.110…

Excited to share our latest work profiling the epigenomic and transcriptional impact of SPOP mutations in normal prostate cells - terrific job by Ivana Grbesa and the rest of the team! biorxiv.org/content/10.110…

Great thanks to my mentors Chris Barbieri Andrea Sboner, PhD @[email protected], all the collaborators, and my funding support from Prostate Cancer Foundation PCF Science

Glad to share our latest work! Key findings are also here: news.weill.cornell.edu/news/2021/05/m… Tweetorial to follow.

Excited for our most recent work published in JCI jci.org/articles/view/…, showing different modes of molecular and clinical progression in distinct molecular subtypes of prostate cancer. A tweetorial thread --> 1/n

.Chris Barbieri Andrea Sboner, PhD @[email protected] Weill Cornell Medicine: Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer: buff.ly/3fLryWT #ClinicalMedicine #Genetics #Oncology

New #prostatecancer models developed by Damon Runyon Clinical Investigator Chris Barbieri and colleagues at Weill Cornell Medicine Urology & NewYork-Presbyterian point to new pathways that could help predict disease #progression: bit.ly/3pZANYg